Skip to main content
Fig. 2 | Cardiovascular Diabetology

Fig. 2

From: Effect of sitagliptin on the echocardiographic parameters of left ventricular diastolic function in patients with type 2 diabetes: a subgroup analysis of the PROLOGUE study

Fig. 2

Percentage changes in E/e′, e′, LVEF, and LVMI at 12 and 24 months in the two treatment groups. Each graph shows sex-, age- and baseline-adjusted least square means (±standard error) at 12 and 24 months. The %change values were calculated as (24 or 12 month data-baseline)/baseline. E/e′ at 24 months shows significant difference between the two groups. E peak early diastolic transmitral flow velocity, e′ peak early diastolic mitral annular velocity, LVEF left ventricular ejection fraction, LVMI left ventricular mass index. *p = 0.002 vs. sitagliptin group

Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840